Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KURA
#2246
Kura Oncology, Inc.
8.7
3
+4.30%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+4.30%
Monthly Change
+3.44%
6 month change
+9.54%
Cambio anual
+14.87%
Cierres anteriores
8.3
7
Open
8.7
3
Bid
Ask
Low
8.7
3
High
8.7
3
Volumen
85
Markets
Acciones
Atención Sanitaria
KURA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
66.21 M
66.61 M
68.44 M
76.14 M
80.75 M
—
Valuation ratios
Enterprise value
1.84 B
841.93 M
772.88 M
1.13 B
478.91 M
2.09 B
Price to earnings ratio
—
—
-5.94
-7.38
-4.31
-13.62
Price to sales ratio
—
—
—
—
13.93
—
Price to cash flow ratio
—
—
-7.33
-9.01
5.59
23.04
Price to book ratio
—
—
1.92
2.83
1.81
3.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.14
0.24
0.3
0.34
0.23
0.31
Return on equity %
0.15
0.26
0.32
0.38
0.42
0.73
Return on invested capital %
-4 731.27
-4 247.5
-4 669.95
-4 398.28
2 520.1
2 898.67
Gross margin %
—
100
—
—
100
—
Operating margin %
—
-61.81 K
—
—
358.55
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
61.54 K
—
—
322.89
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.49
23.26
18.56
12.26
9.46
28.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
—
—
0.09
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.01
0.02
0.02
0.01
0.04
Long term debt to total equity ratio
0.01
0.01
0.02
0.02
0.02
0.08
Per share metrics
Operating cash flow per share
—
—
1.64
1.7
1.56
2.07
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
6.54
5.79
8.44
29.44
Net current asset value per share
—
—
6.66
5.91
8.64
31.55
Tangible book value per share
—
—
6.27
5.43
4.8
15.22
Working capital per share
—
—
6.3
5.42
7.73
27
Book value per share
—
—
6.27
5.43
4.8
15.22
Noticias
Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline
Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline
Citizens reitera calificación de Superar al Mercado para acciones de Kura Oncology
Citizens reitera calificación de Mejor Rendimiento para acciones de Kura Oncology
Citizens reiterates Market Outperform rating on Kura Oncology stock
Kura Oncology’s chief legal officer sells $94,827 in stock
El director comercial de Kura Oncology, Powl, vende acciones por 54.266 dólares
CCO de Kura Oncology, Powl, vende acciones por $54,266
Kura Oncology CCO Powl sells $54,266 in stock
La directora médica de Kura Oncology, Leoni, vende acciones por 69.000 dólares
Kura Oncology SVP sells $60k in shares
Kura Oncology COO Ford sells $15,339 in stock